![](images/sepfull.gif) |
Corporate News
05-Jun-24
|
![](images/sepfull.gif) |
|
|
|
|
|
Torrent Pharmaceuticals enters into patent licensing agreement with Tajeda
|
To commercialize Vonoprazan in India
|
|
|
Torrent Pharmaceuticals (Torrent) today announced that it has entered into a non-exclusive patent licensing agreement with Takeda to commercialize Vonoprazan in India. Vonoprozan is a novel potassium-competitive acid blocker (P-CAB), used for the treatment of acid related disorders - Gastroesophageal Reflux Disease (GERD). Torrent will market Vonoprazan under its own trademark, Kabvie.
As per a 2019 study published by Indian Journal of Gastroenterology prevalence of GERD in Indian population is around 8.2%, with a higher prevalence of around 11.1% in urban population. According to AWACS MAT April 2024 data, the Indian market for treatments used in GERD is valued at INR 8,064 crore, growing at 8% CAGR over the last 4 years. Currently treatments such as Pantoprazole (Proton Pump Inhibitors) are used to treat GERD. Availability of P-CABs such as Kabvie will make accessible new and effective treatments of GERD for the Indian population.
|
|
Previous News |
Torrent Pharmaceuticals to convene AGM
(
Corporate News
-
27-Jun-24
09:10
)
|
|
Torrent Pharma's Indrad facility gets Form 483 with 5 observations from US FDA
(
Hot Pursuit
-
13-Jun-24
09:20
)
|
|
Torrent Pharmaceuticals Ltd spurts 0.36%, up for five straight sessions
(
Hot Pursuit
-
10-Jun-24
13:00
)
|
|
Market opens on firm note; Nifty above 22,700
(
Market Commentary
-
Mid-Session
06-Jun-24
09:41
)
|
|
Torrent Pharmaceuticals enters into patent licensing agreement with Tajeda
(
Corporate News
-
05-Jun-24
16:01
)
|
|
Torrent Pharmaceuticals Ltd spurts 1.81%, rises for third straight session
(
Hot Pursuit
-
29-May-24
13:05
)
|
|
Torrent Pharmaceuticals
(
Results
-
Analysis
27-May-24
12:08
)
|
|
Volumes spurt at Torrent Pharmaceuticals Ltd counter
(
Hot Pursuit
-
27-May-24
11:00
)
|
|
Torrent Pharma spurts as Q4 PAT climbs 56% YoY, board OKs to raise upto Rs 5,000 cr
(
Hot Pursuit
-
27-May-24
10:50
)
|
|
Torrent Pharma Q4 PAT climbs 56% YoY, board OKs to raise upto Rs 5,000 cr
(
Hot Pursuit
-
25-May-24
13:31
)
|
|
Board of Torrent Pharmaceuticals recommends final dividend
(
Corporate News
-
25-May-24
10:36
)
|
|
|
![](images/sepfull.gif) |
Other Stories |
![](images/sepfull.gif) |
|
|
|
|
|
|
|